ANSES withdraws marketing authorisation for certain antiparasitic collars for pets
The news has been added to your library
News of 17/04/2012
17 April 2012
Following its risk re-assessment, ANSES, via the French Agency for Veterinary Medicinal Products, has decided to withdraw marketing authorisation for several antiparasitic collars intended for pets. This decision will lead to batches of the corresponding products being immediately withdrawn from sale from wholesalers and retail outlets.
The French Agency for Veterinary Medicinal Products has decided to withdraw marketing authorisation for several antiparasitic collars for pets.
These medicinal products are used in dogs and cats to eliminate fleas and ticks, and to prevent animals becoming infested with these parasites. They are mainly sold in garden centres, pet stores and supermarkets.
Following a reassessment of antiparasitic collars (conducted according to exposure scenarios referred to as "unfavourable" or "worst case" because they correspond to the maximum exposure that would generate the highest risks for users), potential risks to users, especially children, were identified for some of these collars in the event of chronic exposure, over the long-term and by the dermal route.
As a result, the French Commission for Veterinary Medicinal Products considered that the risk/benefit ratio associated with these collars was unfavourable. On this basis, the French Agency for Veterinary Medicinal Products decided to withdraw marketing authorisation for these antiparasitic medicinal products.
This decision will lead to batches of the corresponding products being immediately withdrawn from sale from wholesalers and retail outlets. The list of antiparasitic collars concerned is attached to this press release.
Finally, the Agency recommends pet owners having purchased any of the products on this list to immediately cease using them, and reminds them that other antiparasitic collars are available on the market.